Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Dengue Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
1 Market Overview1.1 Dengue Vaccines Product Introduction
1.2 Global Dengue Vaccines Market Size Forecast
1.3 Dengue Vaccines Market Trends & Drivers
1.3.1 Dengue Vaccines Industry Trends
1.3.2 Dengue Vaccines Market Drivers & Opportunity
1.3.3 Dengue Vaccines Market Challenges
1.3.4 Dengue Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dengue Vaccines Players Revenue Ranking (2023)
2.2 Global Dengue Vaccines Revenue by Company (2019-2024)
2.3 Key Companies Dengue Vaccines Manufacturing Base Distribution and Headquarters
2.4 Key Companies Dengue Vaccines Product Offered
2.5 Key Companies Time to Begin Mass Production of Dengue Vaccines
2.6 Dengue Vaccines Market Competitive Analysis
2.6.1 Dengue Vaccines Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Dengue Vaccines Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dengvaxia
3.1.2 TAK-003
3.1.3 Others
3.2 Global Dengue Vaccines Sales Value by Type
3.2.1 Global Dengue Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dengue Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Dengue Vaccines Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Public Sector
4.1.2 Private Sector
4.2 Global Dengue Vaccines Sales Value by Application
4.2.1 Global Dengue Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dengue Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Dengue Vaccines Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Dengue Vaccines Sales Value by Region
5.1.1 Global Dengue Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dengue Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Dengue Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Dengue Vaccines Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Dengue Vaccines Sales Value, 2019-2030
5.2.2 North America Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Dengue Vaccines Sales Value, 2019-2030
5.3.2 Europe Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Dengue Vaccines Sales Value, 2019-2030
5.4.2 Asia Pacific Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Dengue Vaccines Sales Value, 2019-2030
5.5.2 South America Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Dengue Vaccines Sales Value, 2019-2030
5.6.2 Middle East & Africa Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dengue Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dengue Vaccines Sales Value
6.3 United States
6.3.1 United States Dengue Vaccines Sales Value, 2019-2030
6.3.2 United States Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dengue Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dengue Vaccines Sales Value, 2019-2030
6.4.2 Europe Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dengue Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dengue Vaccines Sales Value, 2019-2030
6.5.2 China Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dengue Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dengue Vaccines Sales Value, 2019-2030
6.6.2 Japan Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dengue Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dengue Vaccines Sales Value, 2019-2030
6.7.2 South Korea Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dengue Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dengue Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dengue Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dengue Vaccines Sales Value, 2019-2030
6.9.2 India Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dengue Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Profile
7.1.2 Sanofi Main Business
7.1.3 Sanofi Dengue Vaccines Products, Services and Solutions
7.1.4 Sanofi Dengue Vaccines Revenue (US$ Million) & (2019-2024)
7.1.5 Sanofi Recent Developments
7.2 Takeda
7.2.1 Takeda Profile
7.2.2 Takeda Main Business
7.2.3 Takeda Dengue Vaccines Products, Services and Solutions
7.2.4 Takeda Dengue Vaccines Revenue (US$ Million) & (2019-2024)
7.2.5 Takeda Recent Developments
8 Industry Chain Analysis
8.1 Dengue Vaccines Industrial Chain
8.2 Dengue Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dengue Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Dengue Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Figures, Tables and Charts Available in Dengue Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
List of TablesTable 1. Dengue Vaccines Market Trends
Table 2. Dengue Vaccines Market Drivers & Opportunity
Table 3. Dengue Vaccines Market Challenges
Table 4. Dengue Vaccines Market Restraints
Table 5. Global Dengue Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Dengue Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Dengue Vaccines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Dengue Vaccines Product Type
Table 9. Key Companies Time to Begin Mass Production of Dengue Vaccines
Table 10. Global Dengue Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Dengue Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Dengue Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Dengue Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Dengue Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Dengue Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Dengue Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Dengue Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Dengue Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Dengue Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Dengue Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Dengue Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Dengue Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Dengue Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Dengue Vaccines Sales Value by Region (2019-2024) & (%)
Table 27. Global Dengue Vaccines Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Dengue Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Dengue Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Dengue Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 31. Sanofi Basic Information List
Table 32. Sanofi Description and Business Overview
Table 33. Sanofi Dengue Vaccines Products, Services and Solutions
Table 34. Revenue (US$ Million) in Dengue Vaccines Business of Sanofi (2019-2024)
Table 35. Sanofi Recent Developments
Table 36. Takeda Basic Information List
Table 37. Takeda Description and Business Overview
Table 38. Takeda Dengue Vaccines Products, Services and Solutions
Table 39. Revenue (US$ Million) in Dengue Vaccines Business of Takeda (2019-2024)
Table 40. Takeda Recent Developments
Table 41. Key Raw Materials Lists
Table 42. Raw Materials Key Suppliers Lists
Table 43. Dengue Vaccines Downstream Customers
Table 44. Dengue Vaccines Distributors List
Table 45. Research Programs/Design for This Report
Table 46. Key Data Information from Secondary Sources
Table 47. Key Data Information from Primary Sources
Table 48. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Dengue Vaccines Product Picture
Figure 2. Global Dengue Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dengue Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Dengue Vaccines Report Years Considered
Figure 5. Global Dengue Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Dengue Vaccines Revenue in 2023
Figure 7. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Dengvaxia Picture
Figure 9. TAK-003 Picture
Figure 10. Others Picture
Figure 11. Global Dengue Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Dengue Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Public Sector
Figure 14. Product Picture of Private Sector
Figure 15. Global Dengue Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Dengue Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Dengue Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Dengue Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Dengue Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Dengue Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Dengue Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Dengue Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Dengue Vaccines Sales Value (%), (2019-2030)
Figure 28. United States Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 34. China Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 36. China Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 46. India Dengue Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Dengue Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 48. India Dengue Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 49. Dengue Vaccines Industrial Chain
Figure 50. Dengue Vaccines Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
REQUEST COMPANIES MENTIONED IN THIS REPORT
